Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Sci Rep ; 9(1): 14594, 2019 10 10.
Artigo em Inglês | MEDLINE | ID: mdl-31601915

RESUMO

In a previous study we reported that prediabetic rats have a unique gene signature that was apparent even in neonates. Several of the changes we observed, including enhanced expression of pro-inflammatory genes and dysregulated UPR and metabolism genes were first observed in the liver followed by the pancreas. In the present study we investigated further early changes in hepatic innate immunity and metabolism in two models of type 1 diabetes (T1D), the BBdp rat and NOD mouse. There was a striking increase in lipid deposits in liver, particularly in neonatal BBdp rats, with a less striking but significant increase in neonatal NOD mice in association with dysregulated expression of lipid metabolism genes. This was associated with a decreased number of extramedullary hematopoietic clusters as well as CD68+ macrophages in the liver of both models. In addition, PPARÉ£ and phosphorylated AMPKα protein were decreased in neonatal BBdp rats. BBdp rats displayed decreased expression of antimicrobial genes in neonates and decreased M2 genes at 30 days. This suggests hepatic steatosis could be a common early feature in development of T1D that impacts metabolic homeostasis and tolerogenic phenotype in the prediabetic liver.


Assuntos
Fígado Gorduroso/imunologia , Fígado Gorduroso/fisiopatologia , Imunidade Inata , Metabolismo dos Lipídeos , Animais , Animais Recém-Nascidos , Antígenos CD/metabolismo , Antígenos de Diferenciação Mielomonocítica/metabolismo , Diabetes Mellitus Tipo 1/imunologia , Diabetes Mellitus Tipo 1/fisiopatologia , Modelos Animais de Doenças , Feminino , Perfilação da Expressão Gênica , Fígado/metabolismo , Fígado/fisiopatologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos NOD , Fenótipo , Fosforilação , Reação em Cadeia da Polimerase , Ratos , Triglicerídeos/metabolismo
2.
Biochim Biophys Acta Mol Cell Res ; 1864(4): 708-718, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27993671

RESUMO

Autophagy is a catabolic process that targets and degrades cytoplasmic materials. In skeletal muscle, autophagy is required for the control of mass under catabolic conditions, but is also basally active in the maintenance of myofiber homeostasis. In this study, we found that some specific autophagic markers (LC3-I, LC3-II, SQSTM1) were basally lower in glycolytic muscle compared to oxidative muscle of autophagy competent mice. In contrast, basal autophagic flux was higher in glycolytic muscle. In addition, we used several skeletal muscle-specific Atg7 transgenic mouse models to investigate the effect of acute (iAtg7-/-) and chronic (cAtg7-/-) autophagy deficiency on skeletal muscle morphology, contractility, and apoptotic signaling. While acute autophagy ablation (iAtg7-/-) resulted in increased centralized nuclei in glycolytic muscle, it did not alter contractile properties or measures of apoptosis and proteolysis. In contrast, with chronic autophagy deficiency (cAtg7-/-) there was an increased proportion of centralized nuclei, as well as reduced force and altered twitch kinetics in glycolytic muscle. Glycolytic muscle of cAtg7-/- mice also displayed an increased level of the pro-apoptotic protein BAX, as well as calpain and proteasomal enzymatic activity. Collectively, our data demonstrate cumulative damage from chronic skeletal muscle-specific autophagy deficiency with associated apoptotic and proteasomal upregulation. These findings point towards the importance of investigating different muscle/fiber types when studying skeletal muscle autophagy, and the critical role of autophagy in the maintenance of myofiber function, integrity, and cellular health.


Assuntos
Proteína 7 Relacionada à Autofagia/genética , Autofagia/genética , Células Musculares/metabolismo , Músculo Esquelético/metabolismo , Proteína X Associada a bcl-2/metabolismo , Animais , Apoptose , Proteína 7 Relacionada à Autofagia/deficiência , Calpaína/genética , Calpaína/metabolismo , Núcleo Celular/metabolismo , Núcleo Celular/ultraestrutura , Regulação da Expressão Gênica , Glicólise/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Proteínas Associadas aos Microtúbulos/genética , Proteínas Associadas aos Microtúbulos/metabolismo , Células Musculares/patologia , Contração Muscular , Músculo Esquelético/patologia , Fosforilação Oxidativa , Complexo de Endopeptidases do Proteassoma/metabolismo , Proteólise , Proteína Sequestossoma-1/genética , Proteína Sequestossoma-1/metabolismo , Transdução de Sinais , Proteína X Associada a bcl-2/genética
3.
Prim Care ; 26(2): 243-78, 1999 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10318747

RESUMO

Managing patients with personality disorders is an unfortunate, yet inevitable, aspect of the primary care practice. The epidemiology and origin of these disorders are briefly discussed. This article discusses both formal criteria for diagnosis and informal indicators that are clues for the physician to consider these disorders. In addition, relevant clinical cases are presented and reviewed. This article also outlines some practical management strategies to help the physician more effectively and efficiently deal with these troublesome patients.


Assuntos
Medicina de Família e Comunidade/métodos , Transtornos da Personalidade/diagnóstico , Transtornos da Personalidade/terapia , Atenção Primária à Saúde/métodos , Adulto , Atitude do Pessoal de Saúde , Mecanismos de Defesa , Diagnóstico Diferencial , Feminino , Humanos , Internet , Masculino , Transtornos da Personalidade/epidemiologia , Transtornos da Personalidade/etiologia , Transtornos da Personalidade/psicologia , Médicos/psicologia , Psicoterapia , Recusa em Tratar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA